Zeng, Y. (2026) “Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells”, European Journal of Histochemistry, 70(2). doi:10.4081/ejh.2026.4540.